ResearcherNomocan Pharmaceuticals, LlcActive in the last 2 years

Ehsan Yazdi

Verified by NIH RePORTER profile ID (good confidence)As of 14 November 2026

Matched on NIH RePORTER profile ID 80494420.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 0
Pancreatic cancer trials: 0
Pancreatic cancer grants: 1
Collaborators: 1

Papers, trials and grants by year

2025: 1 grant

Grants 1

NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTPHA… 75N91025C00 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Yang David Lee · 1 shared grant, 2025
- Grant NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANC… 75N91025C00 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.